- Home
- OPK vs PMT Comparison
OPK vs PMT Comparison
Compare OPK & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- PMT
- Stock Information
- Founded
- OPK 2007
- PMT 2009
- Country
- OPK United States
- PMT United States
- Employees
- OPK N/A
- PMT N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- PMT Real Estate Investment Trusts
- Sector
- OPK Health Care
- PMT Real Estate
- Exchange
- OPK Nasdaq
- PMT Nasdaq
- Market Cap
- OPK 1.0B
- PMT 1.1B
- IPO Year
- OPK 1995
- PMT 2009
- Fundamental
- Price
- OPK $1.58
- PMT $13.52
- Analyst Decision
- OPK Strong Buy
- PMT Buy
- Analyst Count
- OPK 3
- PMT 6
- Target Price
- OPK $2.75
- PMT $15.25
- AVG Volume (30 Days)
- OPK 2.9M
- PMT 739.3K
- Earning Date
- OPK 02-25-2025
- PMT 01-30-2025
- Dividend Yield
- OPK N/A
- PMT 11.89%
- EPS Growth
- OPK N/A
- PMT N/A
- EPS
- OPK N/A
- PMT 1.37
- Revenue
- OPK $711,408,000.00
- PMT $504,603,000.00
- Revenue This Year
- OPK N/A
- PMT N/A
- Revenue Next Year
- OPK $0.00
- PMT $3.88
- P/E Ratio
- OPK N/A
- PMT $9.82
- Revenue Growth
- OPK N/A
- PMT N/A
- 52 Week Low
- OPK $0.86
- PMT $11.77
- 52 Week High
- OPK $1.76
- PMT $15.22
- Technical
- Relative Strength Index (RSI)
- OPK 55.91
- PMT 63.51
- Support Level
- OPK $1.47
- PMT $12.64
- Resistance Level
- OPK $1.51
- PMT $13.69
- Average True Range (ATR)
- OPK 0.04
- PMT 0.24
- MACD
- OPK 0.01
- PMT 0.14
- Stochastic Oscillator
- OPK 94.44
- PMT 86.74
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through four segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies, and corporate activities. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.